FDA-Drug2023-10-25Class II
Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL syringes, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Hazard
Lack of Assurance of Sterility
Sold states
Nationwide within the United States
Affected count
2176 syringes
Manufactured in
355 Riverwalk Pkwy, N/A, Tonawanda, NY, United States
Products
Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL syringes, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0058-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief